Авторы, Редакторы, Рецензенты

Andrew J. Garton

Kolltan Pharmaceuticals, Inc., New Haven, CT
Больше информации об авторе - в Directory of Specialists

Articles

Emerging Receptor Tyrosine Kinase Drug Targets: Implications for Antibody-Based Therapies for Oncology and Immunologic Disorders Vol. 20 '2015 - Critical Reviews™ in Oncogenesis